These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator. Watahiki Y; Scully MF; Ellis V; Kakkar VV Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259 [TBL] [Abstract][Full Text] [Related]
6. Determination of the global fibrinolytic state. Stief TW; Fröhlich S; Renz H Blood Coagul Fibrinolysis; 2007 Jul; 18(5):479-87. PubMed ID: 17581324 [TBL] [Abstract][Full Text] [Related]
7. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946 [TBL] [Abstract][Full Text] [Related]
8. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase. Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764 [TBL] [Abstract][Full Text] [Related]
10. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect. Gurewich V; Pannell R Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707 [No Abstract] [Full Text] [Related]
11. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators. Fry ET; Mack DL; Sobel BE Thromb Haemost; 1989 Nov; 62(3):909-16. PubMed ID: 2512679 [TBL] [Abstract][Full Text] [Related]
13. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin. Stief TW; Martín E; Jimenez J; Digón J; Rodriguez JM Thromb Res; 1991 Feb; 61(3):191-200. PubMed ID: 1827545 [TBL] [Abstract][Full Text] [Related]
14. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [TBL] [Abstract][Full Text] [Related]
15. Thrombin converts singlet oxygen (1O2)-oxidized fibrinogen into a soluble t-PA cofactor. A new method for preparing a stimulator for functional t-PA assays. Stief TW; Kretschmer V; Kosche B; Doss MO; Renz H Ann Hematol; 2001 Apr; 80(4):189-94. PubMed ID: 11401083 [TBL] [Abstract][Full Text] [Related]
16. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. Pannell R; Black J; Gurewich V J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831 [TBL] [Abstract][Full Text] [Related]
19. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase. Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163 [TBL] [Abstract][Full Text] [Related]